SXI Life Sciences
7.549,93
PKT
-4,65
PKT
-0,06
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.10.05 | Novartis akkumulieren | Independent Research | |
| 20.10.05 | Novartis buy | Merrill Lynch | |
| 19.10.05 | Novartis outperform | Goldman Sachs | |
| 19.10.05 | Novartis overweight | Lehman Brothers | |
| 20.10.05 | Novartis kaufen | Hamburger Sparkasse | |
| 19.10.05 | Novartis Outperform | Goldman Sachs | |
| 18.10.05 | Novartis neutral | Banc of America Sec. | |
| 19.10.05 | Novartis kaufen | Helaba Trust | |
| 21.10.05 | Novartis buy | Jyske Bank | |
| 18.10.05 | Novartis buy | Merrill Lynch | |
| 18.10.05 | Novartis buy | SEB | |
| 18.10.05 | Novartis Neutral | Banc of America Sec. | |
| 21.10.05 | Novartis halten | National-Bank AG | |
| 19.10.05 | Novartis market perform | Piper Jaffray | |
| 19.10.05 | Novartis overweight | Prudential Financial | |
| 17.10.05 | Novartis kaufen | Helaba Trust | |
| 18.10.05 | Novartis buy | Jyske Bank | |
| 11.10.05 | Novartis Neutral | Oppenheimer | |
| 07.10.05 | Lonza kaufen | Berenberg Bank | |
| 07.10.05 | Novartis | DZ-Bank | |
| 07.10.05 | Novartis overweight | Morgan Stanley | |
| 11.10.05 | Novartis buy | Jyske Bank | |
| 06.10.05 | Novartis | Zürcher Kantonalbank | |
| 05.10.05 | Novartis neutral | Susquehanna Financial | |
| 04.10.05 | Novartis Neutral | Susquehanna Financial | |
| 03.10.05 | Novartis buy | Deutsche Bank | |
| 04.10.05 | Novartis market perform | Piper Jaffray | |
| 30.09.05 | Novartis | DZ-Bank | |
| 30.09.05 | Novartis overweight | Prudential Financial | |
| 30.09.05 | Novartis outperform | WestLB | |
| 23.09.05 | Novartis | DZ-Bank | |
| 27.09.05 | Novartis buy | Jyske Bank | |
| 23.09.05 | Novartis outperform | HypoVereinsbank | |
| 21.09.05 | Novartis neutral | Bank Sarasin & Cie | |
| 22.09.05 | Novartis kaufen | Helaba Trust | |
| 21.09.05 | Novartis akkumulieren | Independent Research | |
| 20.09.05 | Novartis akkumulieren | Independent Research | |
| 16.09.05 | Novartis | DZ-Bank | |
| 16.09.05 | Lonza overweight | JP Morgan | |
| 20.09.05 | Novartis buy | Jyske Bank |